Journal of Clinical Oncology, Vol 21, Issue 20
(October), 2003: 3737-3743
© 2003 American Society for Clinical Oncology
Randomized Trial of Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy Versus Systemic Chemotherapy and Palliative Surgery in Patients With Peritoneal Carcinomatosis of Colorectal Cancer
Vic J. Verwaal,
Serge van Ruth,
Eelco de Bree,
Gooike W. van Slooten,
Harm van Tinteren,
Henk Boot,
Frans A.N. Zoetmulder
From the Departments of Surgery, Biometrics, and Gastroenterology, Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.
Address reprint requests to Vic J. Verwaal, MD, Department of Surgery, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands; e-mail: v.verwaal{at}nki.nl.
Purpose: To confirm the findings from uncontrolled studies that aggressive cytoreduction in combination with hyperthermic intraperitoneal chemotherapy (HIPEC) is superior to standard treatment in patients with peritoneal carcinomatosis of colorectal cancer origin.
Patients and Methods: Between February 1998 and August 2001, 105 patients were randomly assigned to receive either standard treatment consisting of systemic chemotherapy (fluorouracil-leucovorin) with or without palliative surgery, or experimental therapy consisting of aggressive cytoreduction with HIPEC, followed by the same systemic chemotherapy regime. The primary end point was survival.
Results: After a median follow-up period of 21.6 months, the median survival was 12.6 months in the standard therapy arm and 22.3 months in the experimental therapy arm (log-rank test, P = .032). The treatment-related mortality in the aggressive therapy group was 8%. Most complications from HIPEC were related to bowel leakage. Subgroup analysis of the HIPEC group showed that patients with 0 to 5 of the 7 regions of the abdominal cavity involved by tumor at the time of the cytoreduction had a significantly better survival than patients with 6 or 7 affected regions (log-rank test, P < .0001). If the cytoreduction was macroscopically complete (R-1), the median survival was also significantly better than in patients with limited (R-2a), or extensive residual disease (R-2b; log-rank test, P < .0001).
Conclusion: Cytoreduction followed by HIPEC improves survival in patients with peritoneal carcinomatosis of colorectal origin. However, patients with involvement of six or more regions of the abdominal cavity, or grossly incomplete cytoreduction, had still a grave prognosis.
Supported with grant OG98-041 from Ontwikkelings Geneeskunde.
 CiteULike  Complore  Connotea  Del.icio.us  Digg  Facebook  Reddit  Technorati  Twitter What's this?
Related Correspondence
- Intraperitoneal Hyperthermic Chemotherapy As Treatment of Peritoneal Carcinomatosis of Colorectal Cancer
Maurie Markman
JCO 2004 22: 1527
[Full Text]
- Hyperthermic Intraperitoneal Chemotherapy in Patients With Peritoneal Carcinosis
Bert Hildebrandt, Beate Rau, Johanna Gellermann, Peter Wust, and Hanno Riess
JCO 2004 22: 1527-1529
[Full Text]
Related Reply
This article has been cited by other articles:
|
|
|
|
 
D. C. Gammon, T. Dutton, B. Piperdi, J. Zybert, S. H. Wolfe, E. Nguyen, D. Sbat, V. G. Pillarisetty, M. Sullivan, and G. F. Whalen
Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy in the treatment of peritoneal carcinomatosis
Am. J. Health Syst. Pharm.,
July 1, 2009;
66(13):
1186 - 1190.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. VAIRA, T. CIOPPA, G. DE MARCO, C. BING, S. D'AMICO, M. D'ALESSANDRO, G. FIORENTINI, and M. DE SIMONE
Management of Pseudomyxoma Peritonei by Cytoreduction+HIPEC (Hyperthermic Intraperitoneal Chemotherapy): Results Analysis of a Twelve-year Experience
In Vivo,
July 1, 2009;
23(4):
639 - 644.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. CAVALIERE, D. GIANNARELLI, M. VALLE, O. FEDERICI, G. LIOTTA, P. PERRI, F. DI FILIPPO, A. GAROFALO, and P. IALONGO
Peritoneal Carcinomatosis from Ovarian Epithelial Primary: Combined Aggressive Treatment
In Vivo,
May 1, 2009;
23(3):
441 - 446.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Elias, J. H. Lefevre, J. Chevalier, A. Brouquet, F. Marchal, J.-M. Classe, G. Ferron, J.-M. Guilloit, P. Meeus, D. Goere, et al.
Complete Cytoreductive Surgery Plus Intraperitoneal Chemohyperthermia With Oxaliplatin for Peritoneal Carcinomatosis of Colorectal Origin
J. Clin. Oncol.,
February 10, 2009;
27(5):
681 - 685.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. M. Foster, Z. Gatalica, S. Lilleberg, G. Haynatzki, and B. W. Loggie
Novel and Existing Mutations in the Tyrosine Kinase Domain of the Epidermal Growth Factor Receptor are Predictors of Optimal Resectability in Malignant Peritoneal Mesothelioma
Ann. Surg. Oncol.,
January 1, 2009;
16(1):
152 - 158.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. H. Sugarbaker
Comprehensive Management of Disseminated Colorectal Cancer
Ann. Surg. Oncol.,
December 1, 2008;
15(12):
3327 - 3330.
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Shen, K. Thai, J. H. Stewart, R. Howerton, B. W. Loggie, G. B. Russell, and E. A. Levine
Peritoneal Surface Disease from Colorectal Cancer: Comparison with the Hepatic Metastases Surgical Paradigm in Optimally Resected Patients
Ann. Surg. Oncol.,
December 1, 2008;
15(12):
3422 - 3432.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Franko, N. J. Gusani, M. P. Holtzman, S. A. Ahrendt, H. L. Jones, H. J. Zeh III, and D. L. Bartlett
Multivisceral Resection Does Not Affect Morbidity and Survival After Cytoreductive Surgery and Chemoperfusion for Carcinomatosis from Colorectal Cancer
Ann. Surg. Oncol.,
November 1, 2008;
15(11):
3065 - 3072.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. A. Levine
The Randomized Trial of Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemoperfusion: What It Does and Does Not Tell Us
Ann. Surg. Oncol.,
October 1, 2008;
15(10):
2633 - 2635.
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. J. Verwaal, S. Bruin, H. Boot, G. van Slooten, and H. van Tinteren
8-Year Follow-up of Randomized Trial: Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy Versus Systemic Chemotherapy in Patients with Peritoneal Carcinomatosis of Colorectal Cancer
Ann. Surg. Oncol.,
September 1, 2008;
15(9):
2426 - 2432.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. L. Bartlett
HIPEC: The Complexities of Clinical Trials
Ann. Surg. Oncol.,
May 1, 2008;
15(5):
1277 - 1279.
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. E. Harrison, M. Bryan, L. Pliner, and T. Saunders
Phase I Trial of Pegylated Liposomal Doxorubicin with Hyperthermic Intraperitoneal Chemotherapy in Patients Undergoing Cytoreduction for Advanced Intra-abdominal Malignancy
Ann. Surg. Oncol.,
May 1, 2008;
15(5):
1407 - 1413.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. L. van Leeuwen, W. Graf, L. Pahlman, and H. Mahteme
Swedish Experience with Peritonectomy and HIPEC. HIPEC in Peritoneal Carcinomatosis
Ann. Surg. Oncol.,
March 1, 2008;
15(3):
745 - 753.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. J. Gusani, S. W. Cho, C. Colovos, S. Seo, J. Franko, S. D. Richard, R. P. Edwards, C. K. Brown, M. P. Holtzman, H. J. Zeh, et al.
Aggressive Surgical Management of Peritoneal Carcinomatosis With Low Mortality in a High-Volume Tertiary Cancer Center
Ann. Surg. Oncol.,
March 1, 2008;
15(3):
754 - 763.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. P. Ceelen, M. Peeters, P. Houtmeyers, C. Breusegem, F. De Somer, and P. Pattyn
Safety and Efficacy of Hyperthermic Intraperitoneal Chemoperfusion with High-Dose Oxaliplatin in Patients with Peritoneal Carcinomatosis
Ann. Surg. Oncol.,
February 1, 2008;
15(2):
535 - 541.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Benoit, N. Cheynel, P. Ortega-Deballon, G. Di Giacomo, B. Chauffert, and P. Rat
Closed Hyperthermic Intraperitoneal Chemotherapy with Open Abdomen: a Novel Technique to Reduce Exposure of the Surgical Team to Chemotherapy Drugs
Ann. Surg. Oncol.,
February 1, 2008;
15(2):
542 - 546.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. P. McQuellon, G. B. Russell, P. Shen, J. H. Stewart IV, W. Saunders, and E. A. Levine
Survival and Health Outcomes After Cytoreductive Surgery With Intraperitoneal Hyperthermic Chemotherapy for Disseminated Peritoneal Cancer of Appendiceal Origin
Ann. Surg. Oncol.,
January 1, 2008;
15(1):
125 - 133.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Gesson-Paute, G. Ferron, F. Thomas, E. C. de Lara, E. Chatelut, and D. Querleu
Pharmacokinetics of Oxaliplatin During Open Versus Laparoscopically Assisted Heated Intraoperative Intraperitoneal Chemotherapy (HIPEC): An Experimental Study
Ann. Surg. Oncol.,
January 1, 2008;
15(1):
339 - 344.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. A. Levine, B. M. Ronnett, P. F. Mansfield, and C. Eng
Overview of Cytoreductive Surgery and Intraperitoneal Hyperthermic Chemotherapy for Peritoneal Dissemination of Appendiceal and Colorectal Neoplasms
ASCO Educational Book,
January 1, 2008;
2008(1):
153 - 159.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Kusamura, D. Baratti, A. Antonucci, R. Younan, B. Laterza, G. D. Oliva, C. Gavazzi, and M. Deraco
Incidence of Postoperative Pancreatic Fistula and Hyperamylasemia after Cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy
Ann. Surg. Oncol.,
December 1, 2007;
14(12):
3443 - 3452.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Bijelic, A. Jonson, and P. H. Sugarbaker
Systematic review of cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis in primary and recurrent ovarian cancer
Ann. Onc.,
December 1, 2007;
18(12):
1943 - 1950.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Aarts, T. Hendriks, O. C. Boerman, M. J. Koppe, W. J. G. Oyen, and R. P. Bleichrodt
A Comparison Between Radioimmunotherapy and Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Peritoneal Carcinomatosis of Colonic Origin in Rats
Ann. Surg. Oncol.,
November 1, 2007;
14(11):
3274 - 3282.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. D. Yan, D. Black, P. H. Sugarbaker, J. Zhu, Y. Yonemura, G. Petrou, and D. L. Morris
A Systematic Review and Meta-analysis of the Randomized Controlled Trials on Adjuvant Intraperitoneal Chemotherapy for Resectable Gastric Cancer
Ann. Surg. Oncol.,
October 1, 2007;
14(10):
2702 - 2713.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Kusamura, D. Baratti, R. Younan, B. Laterza, G. D. Oliva, P. Costanzo, M. Favaro, C. Gavazzi, F. Grosso, and M. Deraco
Impact of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy on Systemic Toxicity
Ann. Surg. Oncol.,
September 1, 2007;
14(9):
2550 - 2558.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. D. Yan, M. Links, S. Fransi, T. Jacques, D. Black, V. Saunders, and D. L. Morris
Learning Curve for Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy for Peritoneal Surface Malignancy A Journey to Becoming a Nationally Funded Peritonectomy Center
Ann. Surg. Oncol.,
August 1, 2007;
14(8):
2270 - 2280.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Bijelic, T. D. Yan, and P. H. Sugarbaker
Failure Analysis of Recurrent Disease Following Complete Cytoreduction and Perioperative Intraperitoneal Chemotherapy in Patients with Peritoneal Carcinomatosis from Colorectal Cancer
Ann. Surg. Oncol.,
August 1, 2007;
14(8):
2281 - 2288.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. D. Yan, J. Sim, and D. L. Morris
Selection of Patients with Colorectal Peritoneal Carcinomatosis for Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy
Ann. Surg. Oncol.,
June 1, 2007;
14(6):
1807 - 1817.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Elias, D. Goere, F. Blot, V. Billard, M. Pocard, N. Kohneh-Shahri, and B. Raynard
Optimization of Hyperthermic Intraperitoneal Chemotherapy With Oxaliplatin Plus Irinotecan at 43{degrees}C After Compete Cytoreductive Surgery: Mortality and Morbidity in 106 Consecutive Patients
Ann. Surg. Oncol.,
June 1, 2007;
14(6):
1818 - 1824.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Yan, L Welch, D Black, and P. Sugarbaker
A systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for diffuse malignancy peritoneal mesothelioma
Ann. Onc.,
May 1, 2007;
18(5):
827 - 834.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. J. Morgan Jr., T. W. Synold, B. Xi, D. Lim, S. Shibata, K. Margolin, R. E. Schwarz, L. Leong, G. Somlo, P. Twardowski, et al.
Phase I Trial of Intraperitoneal Gemcitabine in the Treatment of Advanced Malignancies Primarily Confined to the Peritoneal Cavity
Clin. Cancer Res.,
February 15, 2007;
13(4):
1232 - 1237.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. P. Parungo, D. I. Soybel, Y. L. Colson, S.-W. Kim, S. Ohnishi, A. M. DeGrand, R. G. Laurence, E. G. Soltesz, F. Y. Chen, L. H. Cohn, et al.
Lymphatic Drainage of the Peritoneal Space: A Pattern Dependent on Bowel Lymphatics: Resident/Fellow Essay Award Winner for the Best Clinical Research Paper Basic Science and Special Investigator Award Winners
Ann. Surg. Oncol.,
February 1, 2007;
14(2):
286 - 298.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Elias, E. Benizri, D. DiPietrantonio, P. Menegon, D. Malka, and B. Raynard
Comparison of Two Kinds of Intraperitoneal Chemotherapy Following Complete Cytoreductive Surgery of Colorectal Peritoneal Carcinomatosis
Ann. Surg. Oncol.,
February 1, 2007;
14(2):
509 - 514.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. D. Yan, G. Edwards, R. Alderman, C. E. Marquardt, and P. H. Sugarbaker
Morbidity and Mortality Assessment of Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy for Diffuse Malignant Peritoneal Mesothelioma--A Prospective Study of 70 Consecutive Cases
Ann. Surg. Oncol.,
February 1, 2007;
14(2):
515 - 525.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Esquivel, R. Sticca, P. Sugarbaker, E. Levine, T. D. Yan, R. Alexander, D. Baratti, D. Bartlett, R. Barone, P. Barrios, et al.
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in the Management of Peritoneal Surface Malignancies of Colonic Origin: A Consensus Statement
Ann. Surg. Oncol.,
January 1, 2007;
14(1):
128 - 133.
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. M. Tuttle, Y. Zhang, E. Greeno, and A. Knutsen
Toxicity and Quality of Life after Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy
Ann. Surg. Oncol.,
December 1, 2006;
13(12):
1627 - 1632.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Links
Analogies between reading of medical and religious texts
BMJ,
November 18, 2006;
333(7577):
1068 - 1070.
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. J. Koppe, T. Hendriks, O. C. Boerman, W. J.G. Oyen, and R. P. Bleichrodt
Radioimmunotherapy Is an Effective Adjuvant Treatment After Cytoreductive Surgery of Experimental Colonic Peritoneal Carcinomatosis
J. Nucl. Med.,
November 1, 2006;
47(11):
1867 - 1874.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. D. Yan, D. Black, R. Savady, and P. H. Sugarbaker
Systematic Review on the Efficacy of Cytoreductive Surgery Combined With Perioperative Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis From Colorectal Carcinoma
J. Clin. Oncol.,
August 20, 2006;
24(24):
4011 - 4019.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. M. Kane III
The "Alphabet Soup" of Peritoneal Dissemination From Appendiceal Neoplasms and Other Malignancies
Ann. Surg. Oncol.,
May 1, 2006;
13(5):
597 - 599.
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. H. Sugarbaker
Decreasing the Risk of a Treatment Expands Its Indications
Ann. Surg. Oncol.,
November 1, 2005;
12(11):
868 - 870.
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Elias, G. Liberale, D. Vernerey, M. Pocard, M. Ducreux, V. Boige, D. Malka, J.-P. Pignon, and P. Lasser
Hepatic and Extrahepatic Colorectal Metastases: When Resectable, Their Localization Does Not Matter, But Their Total Number Has a Prognostic Effect
Ann. Surg. Oncol.,
November 1, 2005;
12(11):
900 - 909.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Younan, S. Kusamura, D. Baratti, G. D. Oliva, P. Costanzo, M. Favaro, C. Gavazzi, and M. Deraco
Bowel Complications in 203 Cases of Peritoneal Surface Malignancies Treated With Peritonectomy and Closed-Technique Intraperitoneal Hyperthermic Perfusion
Ann. Surg. Oncol.,
November 1, 2005;
12(11):
910 - 918.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. H. Stewart IV, P. Shen, and E. A. Levine
Intraperitoneal Hyperthermic Chemotherapy for Peritoneal Surface Malignancy: Current Status and Future Directions
Ann. Surg. Oncol.,
October 1, 2005;
12(10):
765 - 777.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. H Sugarbaker, O. A. Stuart, and D. Yoo
Strategies for management of the peritoneal surface component of cancer: cytoreductive surgery plus perioperative intraperitoneal chemotherapy
Journal of Oncology Pharmacy Practice,
September 1, 2005;
11(3):
111 - 119.
[Abstract]
[PDF]
|
|
|
|
|
|
|
P. H. Sugarbaker, J. T. Mora, P. Carmignani, O. A. Stuart, and D. Yoo
Update on Chemotherapeutic Agents Utilized for Perioperative Intraperitoneal Chemotherapy
Oncologist,
February 1, 2005;
10(2):
112 - 122.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. J. Verwaal, S. van Ruth, A. Witkamp, H. Boot, G. van Slooten, and F. A. N. Zoetmulder
Long-Term Survival of Peritoneal Carcinomatosis of Colorectal Origin
Ann. Surg. Oncol.,
January 1, 2005;
12(1):
65 - 71.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Elias, T. Matsuhisa, L. Sideris, G. Liberale, L. Drouard-Troalen, B. Raynard, M. Pocard, J. M. Puizillou, V. Billard, P. Bourget, et al.
Heated intra-operative intraperitoneal oxaliplatin plus irinotecan after complete resection of peritoneal carcinomatosis: pharmacokinetics, tissue distribution and tolerance
Ann. Onc.,
October 1, 2004;
15(10):
1558 - 1565.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
O. Glehen, F. Kwiatkowski, P.H. Sugarbaker, D. Elias, E.A. Levine, M. De Simone, R. Barone, Y. Yonemura, F. Cavaliere, F. Quenet, et al.
Cytoreductive Surgery Combined With Perioperative Intraperitoneal Chemotherapy for the Management of Peritoneal Carcinomatosis From Colorectal Cancer: A Multi-Institutional Study
J. Clin. Oncol.,
August 15, 2004;
22(16):
3284 - 3292.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. Chau, A. R. Norman, D. Cunningham, J. S. Waters, J. Oates, and P. J. Ross
Multivariate Prognostic Factor Analysis in Locally Advanced and Metastatic Esophago-Gastric Cancer--Pooled Analysis From Three Multicenter, Randomized, Controlled Trials Using Individual Patient Data
J. Clin. Oncol.,
June 15, 2004;
22(12):
2395 - 2403.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Elias, J.-R. Delperro, L. Sideris, E. Benhamou, M. Pocard, O. Baton, M. Giovannini, and P. Lasser
Treatment of Peritoneal Carcinomatosis From Colorectal Cancer: Impact of Complete Cytoreductive Surgery and Difficulties in Conducting Randomized Trials
Ann. Surg. Oncol.,
May 1, 2004;
11(5):
518 - 521.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Elias, L. Sideris, M. Pocard, C. Ede, D. Ben Hassouna, M. Ducreux, V. Boige, J. F. Cote, and P. Lasser
Efficacy of intraperitoneal chemohyperthermia with oxaliplatin in colorectal peritoneal carcinomatosis. Preliminary results in 24 patients
Ann. Onc.,
May 1, 2004;
15(5):
781 - 785.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Markman
Intraperitoneal Hyperthermic Chemotherapy As Treatment of Peritoneal Carcinomatosis of Colorectal Cancer
J. Clin. Oncol.,
April 15, 2004;
22(8):
1527 - 1527.
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. Hildebrandt, B. Rau, J. Gellermann, P. Wust, and H. Riess
Hyperthermic Intraperitoneal Chemotherapy in Patients With Peritoneal Carcinosis
J. Clin. Oncol.,
April 15, 2004;
22(8):
1527 - 1529.
[Full Text]
|
|
|
|
|
|
|
S. A. Ahmad, J. Kim, J. J. Sussman, D. A. Soldano, L. J. Pennington, L. E. James, and A. M. Lowy
Reduced Morbidity Following Cytoreductive Surgery and Intraperitoneal Hyperthermic Chemoperfusion
Ann. Surg. Oncol.,
April 1, 2004;
11(4):
387 - 392.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. A. Levine
Editorial: Problems of Success and Problems of Failure: Recurrent Disease After Cytoreductive Surgery and Intraperitoneal Chemoperfusion
Ann. Surg. Oncol.,
April 1, 2004;
11(4):
351 - 353.
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. J. Verwaal, H. Boot, B. M. P. Aleman, H. van Tinteren, and F. A. N. Zoetmulder
Recurrences after Peritoneal Carcinomatosis of Colorectal Origin Treated by Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy: Location, Treatment, and Outcome
Ann. Surg. Oncol.,
April 1, 2004;
11(4):
375 - 379.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. M. Elias
Peritoneal Carcinomatosis or Liver Metastases from Colorectal Cancer: Similar Standards for a Curative Surgery?
Ann. Surg. Oncol.,
February 1, 2004;
11(2):
122 - 123.
[Full Text]
[PDF]
|
|
|
|
